<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00863577</url>
  </required_header>
  <id_info>
    <org_study_id>ROV-BEM-2008-01</org_study_id>
    <nct_id>NCT00863577</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Study of Two Oral Bemiparin Formulations</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rovi Pharmaceuticals Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rovi Pharmaceuticals Laboratories</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary pharmacokinetic analysis will be the correlation of the AUC amidolytic anti-Xa&#xD;
      activity&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary pharmacokinetic analysis will be the correlation of the AUC amidolytic anti-Xa activity</measure>
    <time_frame>pre-medication, +1 h , +2 h, +3h, +4 h , +5h, +6 h, +8 h, +10h, +12h, +18 h, +24 h,+25h, +26h, +27h, +28h, +29h, +30h, +32h, +34h, +36h, +42h, +48 h, +60 h and +72 h</time_frame>
  </primary_outcome>
  <enrollment type="Actual">102</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral bemiparin</intervention_name>
    <description>Bemiparin tablets and bemiparin tablets into hard gelatine capsules</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy volunteers: male or female subjects aged between 18 and 45 years&#xD;
&#xD;
          2. Body weight: 65-80 Kg&#xD;
&#xD;
          3. Not meaningful abnormalities in physical examination and in clinical history&#xD;
&#xD;
          4. Without evidence of significant organic or psychiatric illness&#xD;
&#xD;
          5. Hemogram, biochemistry and coagulation in normal values established in the reference&#xD;
             range of the local hospital laboratory&#xD;
&#xD;
          6. Vital signs (blood pressure, heart beat rate and body temperature) and EKG within&#xD;
             normal range&#xD;
&#xD;
          7. Healthy volunteers who are not participating in another clinical trial or have not&#xD;
             done so in the past 2 months&#xD;
&#xD;
          8. Not give blood in the last 4 weeks.&#xD;
&#xD;
          9. Healthy male volunteers who have not received heparin in the past&#xD;
&#xD;
         10. Healthy male volunteers who have accepted to participate in the study and have signed&#xD;
             the written informed consent&#xD;
&#xD;
         11. contraceptive methods double barrel or sterile surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous history of alcoholism, drug dependency, drug abuse or habitual psychoactive&#xD;
             drugs consumption&#xD;
&#xD;
          2. Important consumption of exciting drinks: alcohol consumption &gt; 30 g/day; coffee, tea,&#xD;
             cola &gt; 5 /day&#xD;
&#xD;
          3. Allergy, idiosyncrasy or hypersensitivity to medicines&#xD;
&#xD;
          4. Healthy volunteers who are receiving another medication in the past 15 days&#xD;
&#xD;
          5. Positive serology of hepatitis B, C or HIV&#xD;
&#xD;
          6. Cardiovascular, respiratory, renal, hepatic, endocrine, gastrointestinal, hematologic,&#xD;
             psychiatric, neurological and others events&#xD;
&#xD;
          7. Mayor Surgery in the last 6 months&#xD;
&#xD;
          8. Smoking &gt; 10 cigarettes / day&#xD;
&#xD;
          9. Ethanol, cannabis, cocaine, amphetamine, benzodiazepin or opiate in urine&#xD;
&#xD;
         10. Healthy volunteers with a familiar history evident hemorrhagic episodes&#xD;
&#xD;
         11. positive fecatest and comburtest&#xD;
&#xD;
         12. positive pregnant test&#xD;
&#xD;
         13. Bemiparin contraindication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <study_first_submitted>January 27, 2009</study_first_submitted>
  <study_first_submitted_qc>March 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2009</study_first_posted>
  <last_update_submitted>March 17, 2011</last_update_submitted>
  <last_update_submitted_qc>March 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>Medical Department</name_title>
    <organization>Medical Department</organization>
  </responsible_party>
  <keyword>Healthy volunteers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bemiparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

